US2006258866A1PendingUtilityA1
Carboxylic derivates
Assignee: ASTRAZENECA AB A SWEDEN CORPPriority: Jun 18, 2003Filed: Jun 28, 2006Published: Nov 16, 2006
Est. expiryJun 18, 2023(expired)· nominal 20-yr term from priority
A61P 3/04A61P 43/00A61P 9/00A61P 9/04A61P 9/10A61P 3/06A61P 9/12A61P 3/08A61P 5/50A61P 3/10A61P 25/16A61P 29/00A61P 35/00A61P 25/00A61P 25/28A61P 3/00A61P 27/02A61P 15/08C07C 2601/14C07D 295/185C07C 2601/08C07C 323/41C07B 2200/07C07D 209/14A61P 13/12C07C 255/46C07D 295/135C07C 235/24C07C 233/51C07C 235/22C07C 323/56C07C 309/66C07C 235/20C07C 233/11C07C 2601/04C07C 231/00A61K 31/16
50
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention provides a compound of formula I processes for preparing such compounds, their the utility in treating clinical conditions including lipid disorders (dyslipidemias) whether or not associated with insulin resistance, methods for their therapeutic use and pharmaceutical compositions containing them.
Claims
exact text as granted — not AI-modified1 - 18 . (canceled)
19 . A compound of formula I
as well as optical isomers and racemates therof as well as pharmaceutically acceptable salts, prodrugs, solvates and crystalline forms thereof,
wherein
A is situated in the para position and represents
R is —OR a , wherein R a represents hydrogen;
R 1 is —OR e , wherein R e is alkyl
R 2 is hydrogen;
R 3 and R 4 are hydrogen,;
T represents O;
n represents 1;
R 5 is hydrogen;
R 6 independently represent hydrogen, C 1-13 alkyl, C 2-10 alkenyl or C 2-10 alkynyl each of which is optionally substituted by one or more of the following which may be the same or different: C 3-8 cycloalkyl, C 3-8 cycloalkenyl, aryl, heterocyclyl, heteroaryl, C 1-8 alkoxy (optionally substituted by one or more fluoro), C 3-8 cycloalkoxy, C 3-8 cycloalkenyloxy, aryloxy, heterocyclyloxy, heteroaryloxy, C 3-8 cycloalkyl C 1-8 alkoxy, aryl C 1-8 alkoxy, heterocyclyl C 1-8 alkoxy or heteroaryl C 1-8 alkoxy, fluorine or hydroxy and wherein each of these substituents may optionally be substituted on carbon with one or more substituents which may be the same or different and selected from C 1-8 alkyl, C 3-8 cycloalkyl (optionally substituted by C 1-8 alkyl, C 1-8 alkoxy (optionally substituted by one or more fluoro), halogen, hydroxy, nitro or cyano), aryl (optionally substituted by C 1-8 alkyl, C 1-8 alkoxy (optionally substituted by one or more fluoro), halogen, hydroxy, nitro or cyano), heterocyclyl (optionally substituted by C 1-6 alkyl on any nitrogen), heteroaryl (optionally substituted by C 1-8 alkyl, C 1-8 alkoxy (optionally substituted by one or more fluoro), halogen, hydroxy, nitro or cyano), C 1-8 alkoxy (optionally substituted by one or more fluoro), C 3-8 cycloalkoxy, C 3-8 cycloalkyl C 1-8 alkoxy, aryloxy (optionally substituted by C 1-8 alkyl, C 1-8 alkoxy (optionally substituted by one or more fluoro), halogen, hydroxy, nitro or cyano), aryl C 1-8 alkoxy (wherein the aryl part is optionally substituted by C 1-8 alkyl, C 1-8 alkoxy (optionally substituted by one or more fluoro), halogen, hydroxy, nitro or cyano), halogen, amino, nitro, hydroxy, methylsulfonyl, methylsulfonyloxy, cyano or methylenedioxy,
or R 5 and R 6 independently represent C 3 -C 8 cycloalkyl; C 3 -C 8 cycloalkenyl; aryl; heterocyclyl; or heteroaryl; wherein each of these groups is optionally substituted by one or more of the following: C 1-8 alkyl, C 1-8 alkoxy (optionally substituted by one or more fluoro), halogen, hydroxy, nitro or cyano), aryl (optionally substituted by C 1-8 alkyl, C 1-8 alkoxy (optionally substituted by one or more fluoro), halogen, hydroxy, nitro or cyano;
or R 5 and R 6 together with the nitrogen atom to which they are attached form a single or a fused heterocyclic system.
20 . A compound according to claim 19; wherein, R 6 represents; C 1-3 alkyl, which is optionally substituted by aryl, and wherein the aryl is optionally substituted on carbon with C 1-8 alkoxy.
21 . A compound according to claim 20 ,
wherein, R 6 represents C 1-13 alkyl, substituted by aryl, which in its turn is substituted on carbon with C 1-8 alkoxy.
22 . A compound according to claim 19 , wherein R 5 is H.
23 . A compound according to claim 19 , wherein R 5 is H; and
R 6 represents; C 1-13 alkyl, which is optionally substituted by aryl, and wherein the aryl is optionally substituted on carbon with C 1-8 alkoxy.
24 . A compound according to claim 19 , wherein R 5 is H; and
R 6 represents C 1-13 alkyl, substituted by aryl, which in its turn is substituted on carbon with C 1-8 alkoxy.Join the waitlist — get patent alerts
Track US2006258866A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.